← Scroll for more →
Taysha Gene Therapies, Inc. (TSHA)
Biological Products, (No Diagnostic Substances)
Latest Price
$4.25
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
1.35
P/B Ratio
3.15
Institutional Ownership
91.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 23.89M | $162.0M | 7.34% | +2.19M | 2026-06-30 |
| RA Capital Management, L.P. | 23.56M | $160.0M | 7.24% | -- | 2026-06-30 |
| Goldman Sachs Group Inc | 22.71M | $154.0M | 6.98% | +343.5K | 2026-06-30 |
| BlackRock, Inc. | 20.69M | $140.0M | 6.36% | +2.33M | 2026-06-30 |
| Vestal Point Capital, LP | 19.41M | $132.0M | 5.97% | +1.42M | 2026-06-30 |
| Morgan Stanley | 16.49M | $112.0M | 5.07% | -1.48M | 2026-06-30 |
| Rtw Investments, LP | 13.56M | $92.0M | 4.17% | -120.0K | 2026-06-30 |
| FMR LLC | 13.34M | $90.0M | 4.10% | -984.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 12.48M | $84.0M | 3.84% | +2.25M | 2026-06-30 |
| State Street Corp | 11.42M | $77.0M | 3.51% | +212.8K | 2026-06-30 |